FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591979535> ?p ?o ?g. }

• W2591979535 endingPage "1450" @default.
• W2591979535 startingPage "1444" @default.
• W2591979535 abstract "Purpose Clinical characteristics, therapeutic approaches, and prognosis of late relapse (LR) in patients with classic Hodgkin lymphoma (cHL) are poorly understood. We performed a comprehensive analysis of LR of Hodgkin lymphoma (LR-HL). Methods To estimate the incidence of LR-HL, we retrospectively analyzed 6,840 patients with cHL included in the German Hodgkin Study Group trials HD7 to HD12. Patients who experienced a relapse > 5 years into remission were compared with patients in continued remission for > 5 years and with those who experienced a relapse ≤ 5 years after first diagnosis. Results With a median observation time of 10.3 years, 141 incidences of LR-HL were observed. Cumulative incidences at 10, 15, and 20 years rose linearly and were 2.5%, 4.3%, and 6.9%, respectively. The standardized incidence ratio for HL with respect to age- and sex-matched German reference data was 84.5 (95% CI, 71.2 to 99.7). LR-HL was more frequently observed in patients with early-stage favorable than unfavorable or advanced stage at first diagnosis (15-year cumulative incidence, 5.3% v 3.9% and 3.9%, respectively; P = .01). Overall survival from first diagnosis was worse after LR compared with nonrelapse survivors (10-year estimate, 95.8% v 86.1%; hazard ratio, 2.5; 95% CI, 1.7 to 3.5; P < .001). In patients with LR-HL, survival was better compared with 466 patients with earlier relapse (hazard ratio, 0.6; 95% CI, 0.4 to 0.9, P = .01). Forty-four percent and 49% of patients with LR-HL and earlier relapse, respectively, received stem cell transplantations. Conclusion Apart from treatment-associated adverse effects, survivors after initially successful therapy for cHL are at an 85-fold risk for recurrence of disease compared with the general German population. After risk-adapted treatment strategies, especially in early-stage favorable HL, regular clinical follow-up is recommended for timely detection of LR-HL. With adequate treatment, prognosis of LR-HL is better compared with early relapses." @default.
• W2591979535 created "2017-03-16" @default.
• W2591979535 creator A5000334325 @default.
• W2591979535 creator A5005462552 @default.
• W2591979535 creator A5013527618 @default.
• W2591979535 creator A5040054777 @default.
• W2591979535 creator A5057387418 @default.
• W2591979535 creator A5061291419 @default.
• W2591979535 creator A5064132655 @default.
• W2591979535 creator A5065162388 @default.
• W2591979535 creator A5065655150 @default.
• W2591979535 creator A5075117420 @default.
• W2591979535 creator A5076460303 @default.
• W2591979535 creator A5083085650 @default.
• W2591979535 date "2017-05-01" @default.
• W2591979535 modified "2023-10-16" @default.
• W2591979535 title "Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials" @default.
• W2591979535 cites W2025318905 @default.
• W2591979535 cites W2052322071 @default.
• W2591979535 cites W2065774555 @default.
• W2591979535 cites W2085143233 @default.
• W2591979535 cites W2101873015 @default.
• W2591979535 cites W2127055058 @default.
• W2591979535 cites W2133260927 @default.
• W2591979535 cites W2140801657 @default.
• W2591979535 cites W2142880562 @default.
• W2591979535 cites W21467570 @default.
• W2591979535 cites W2154059556 @default.
• W2591979535 cites W2163695063 @default.
• W2591979535 cites W2211631799 @default.
• W2591979535 cites W2253895657 @default.
• W2591979535 cites W2470133917 @default.
• W2591979535 cites W2498753998 @default.
• W2591979535 cites W2515183449 @default.
• W2591979535 cites W2551216195 @default.
• W2591979535 doi "https://doi.org/10.1200/jco.2016.71.3289" @default.
• W2591979535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28240973" @default.
• W2591979535 hasPublicationYear "2017" @default.
• W2591979535 type Work @default.
• W2591979535 sameAs 2591979535 @default.
• W2591979535 citedByCount "29" @default.
• W2591979535 countsByYear W25919795352017 @default.
• W2591979535 countsByYear W25919795352018 @default.
• W2591979535 countsByYear W25919795352019 @default.
• W2591979535 countsByYear W25919795352020 @default.
• W2591979535 countsByYear W25919795352021 @default.
• W2591979535 countsByYear W25919795352022 @default.
• W2591979535 countsByYear W25919795352023 @default.
• W2591979535 crossrefType "journal-article" @default.
• W2591979535 hasAuthorship W2591979535A5000334325 @default.
• W2591979535 hasAuthorship W2591979535A5005462552 @default.
• W2591979535 hasAuthorship W2591979535A5013527618 @default.
• W2591979535 hasAuthorship W2591979535A5040054777 @default.
• W2591979535 hasAuthorship W2591979535A5057387418 @default.
• W2591979535 hasAuthorship W2591979535A5061291419 @default.
• W2591979535 hasAuthorship W2591979535A5064132655 @default.
• W2591979535 hasAuthorship W2591979535A5065162388 @default.
• W2591979535 hasAuthorship W2591979535A5065655150 @default.
• W2591979535 hasAuthorship W2591979535A5075117420 @default.
• W2591979535 hasAuthorship W2591979535A5076460303 @default.
• W2591979535 hasAuthorship W2591979535A5083085650 @default.
• W2591979535 hasConcept C120665830 @default.
• W2591979535 hasConcept C121332964 @default.
• W2591979535 hasConcept C126322002 @default.
• W2591979535 hasConcept C143998085 @default.
• W2591979535 hasConcept C146357865 @default.
• W2591979535 hasConcept C151730666 @default.
• W2591979535 hasConcept C207103383 @default.
• W2591979535 hasConcept C2779338263 @default.
• W2591979535 hasConcept C2910914307 @default.
• W2591979535 hasConcept C2992779791 @default.
• W2591979535 hasConcept C44249647 @default.
• W2591979535 hasConcept C50382708 @default.
• W2591979535 hasConcept C61511704 @default.
• W2591979535 hasConcept C71924100 @default.
• W2591979535 hasConcept C72563966 @default.
• W2591979535 hasConcept C86803240 @default.
• W2591979535 hasConcept C88879693 @default.
• W2591979535 hasConcept C90924648 @default.
• W2591979535 hasConceptScore W2591979535C120665830 @default.
• W2591979535 hasConceptScore W2591979535C121332964 @default.
• W2591979535 hasConceptScore W2591979535C126322002 @default.
• W2591979535 hasConceptScore W2591979535C143998085 @default.
• W2591979535 hasConceptScore W2591979535C146357865 @default.
• W2591979535 hasConceptScore W2591979535C151730666 @default.
• W2591979535 hasConceptScore W2591979535C207103383 @default.
• W2591979535 hasConceptScore W2591979535C2779338263 @default.
• W2591979535 hasConceptScore W2591979535C2910914307 @default.
• W2591979535 hasConceptScore W2591979535C2992779791 @default.
• W2591979535 hasConceptScore W2591979535C44249647 @default.
• W2591979535 hasConceptScore W2591979535C50382708 @default.
• W2591979535 hasConceptScore W2591979535C61511704 @default.
• W2591979535 hasConceptScore W2591979535C71924100 @default.
• W2591979535 hasConceptScore W2591979535C72563966 @default.
• W2591979535 hasConceptScore W2591979535C86803240 @default.
• W2591979535 hasConceptScore W2591979535C88879693 @default.
• W2591979535 hasConceptScore W2591979535C90924648 @default.
• W2591979535 hasIssue "13" @default.

• next